Abstract:The study attempts to make a comparison of financial strength between Square Pharmaceuticals Limited (SQPL) and Beximco Pharmaceuticals Limited (BXPL) by using the technique of DuPont analysis. Pharmaceuticals are selected here based on a purposive sampling method with the criteria of convenience in annual reports availability. The research is based on secondary data available in annual reports of FY 2018-19 of the selected companies. The study reveals that in comparison with BXPL, SQPL has been utilizing its owners’ funds more profitably, doing operational activities more efficiently, and earning enough returns for its owners. Beximco Pharmaceuticals Ltd. applies aggressive debt-equity policy, which does not magnify its earnings due to the lack of its sufficient rate of returns in comparison with interest burden, lack of core operational efficiency, and underutilization of resources. At the same time, leverage helps the SQPL to fuel the growth of the business. There is a good thing that the two companies have almost the same amount of tax burden ratio, although EBIT is highly differing between the companies. The study suggests that to achieve a high RoE, Beximco Pharmaceuticals Company must reduce its interest expenses, utilize its full capacities, and increase its assets turnover. Besides, both the pharmaceuticals are suggested to focus on the inflation-adjusted financial items in its annual reports. The study has operated only on DuPont analysis. Thus further research is recommended to conduct focusing on others such as common-size analysis, comparative analysis, trend analysis, and ratio analysis, etc. to investigate the financial health of pharmaceutical companies.

A STUDY ON FINANCIAL PERFORMANCE OF INDIAN PHARMACEUTICAL COMPANIES USING DUPONT ANALYSIS

A Study of Multilayered Profitability Analysis by Using DuPont Model: Evidence from Indian Pharmaceutical Industry

A Study of Financial Performance Using DuPont Analysis in a Supply Chain

Study of Financial Performance of Cement Industry by Using Du-pont Analysis

Financial Performance Analysis of Pharmaceutical Industry in India

Effect of COVID-19 on Dupont based financial performance of three Nationalized Petroleum Companies in India

Financial Statement Analysis of Infosys and Wipro through DUPONT Analysis

Financial Performance Evaluation of Select Listed Companies of NSE-Emerge Using DuPont Analysis

A depth study on financial performance of selected Indian pharmaceutical companies listed on NSE

A study on financial performance of pharmaceutical industry in india

Using DuPont analysis to assess the financial performance of the top 3 JSE listed companies in the food industry

COMPARISON OF PROFITABILITY FOR PHARMACEUTICAL ROMANIAN LISTED COMPANIES USING DUPONT IDENTITY

Dupont System Analysis For Measure Financial Performance At Automotive Component Industry In Indonesia

Comparison of the Financial Performance between Square Pharmaceuticals Limited and Beximco Pharmaceuticals Limited: DuPont Analysis

Effect of Financial Performance on Profitability in Indian Pharmaceutical Companies

A Study of Financial Performance using DuPont Analysis in Food Distribution Market

A COMPARATIVE STUDY ON SELECTED INDIAN BANKS' FINANCIAL RATIOS FOR THE PERIOD FROM FY 2017–2021